144 related articles for article (PubMed ID: 10805335)
1. Glutamate uptake is decreased in platelets from Alzheimer's disease patients.
Ferrarese C; Begni B; Canevari C; Zoia C; Piolti R; Frigo M; Appollonio I; Frattola L
Ann Neurol; 2000 May; 47(5):641-3. PubMed ID: 10805335
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast glutamate transport in aging and in AD: correlations with disease severity.
Zoia CP; Tagliabue E; Isella V; Begni B; Fumagalli L; Brighina L; Appollonio I; Racchi M; Ferrarese C
Neurobiol Aging; 2005 Jun; 26(6):825-32. PubMed ID: 15718040
[TBL] [Abstract][Full Text] [Related]
3. Platelet membrane abnormality in Alzheimer's disease.
Zubenko GS; Cohen BM; Boller F; Malinakova I; Keefe N; Chojnacki B
Ann Neurol; 1987 Aug; 22(2):237-44. PubMed ID: 3662454
[TBL] [Abstract][Full Text] [Related]
4. [Changes of erythrocyte and platelet membrane lipid pattern in different subtypes of dementia].
Chen C; Jia H; Ma H
Zhonghua Yi Xue Za Zhi; 1998 Oct; 78(10):771-3. PubMed ID: 11038832
[TBL] [Abstract][Full Text] [Related]
5. Effects of ageing and Alzheimer's disease on mitochondrial function of human platelets.
Shi C; Guo K; Yew DT; Yao Z; Forster EL; Wang H; Xu J
Exp Gerontol; 2008 Jun; 43(6):589-94. PubMed ID: 18359596
[TBL] [Abstract][Full Text] [Related]
6. Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity.
Praticò D; Clark CM; Lee VM; Trojanowski JQ; Rokach J; FitzGerald GA
Ann Neurol; 2000 Nov; 48(5):809-12. PubMed ID: 11079549
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone.
Hyman BT; Van Hoesen GW; Damasio AR
Ann Neurol; 1987 Jul; 22(1):37-40. PubMed ID: 2443073
[TBL] [Abstract][Full Text] [Related]
8. Platelet serotonin concentration and monoamine oxidase type B activity in female patients in early, middle and late phase of Alzheimer's disease.
Muck-Seler D; Presecki P; Mimica N; Mustapic M; Pivac N; Babic A; Nedic G; Folnegovic-Smalc V
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1226-31. PubMed ID: 19602426
[TBL] [Abstract][Full Text] [Related]
9. Rate of progression in Alzheimer's disease correlates with coated-platelet levels--a longitudinal study.
Prodan CI; Ross ED; Vincent AS; Dale GL
Transl Res; 2008 Sep; 152(3):99-102. PubMed ID: 18774538
[TBL] [Abstract][Full Text] [Related]
10. Regional distribution of amino acid transmitters in postmortem brains of presenile and senile dementia of Alzheimer type.
Sasaki H; Muramoto O; Kanazawa I; Arai H; Kosaka K; Iizuka R
Ann Neurol; 1986 Mar; 19(3):263-9. PubMed ID: 2870679
[TBL] [Abstract][Full Text] [Related]
11. Human platelets tau: a potential peripheral marker for Alzheimer's disease.
Neumann K; Farías G; Slachevsky A; Perez P; Maccioni RB
J Alzheimers Dis; 2011; 25(1):103-9. PubMed ID: 21368381
[TBL] [Abstract][Full Text] [Related]
12. Low serum VEGF levels are associated with Alzheimer's disease.
Mateo I; Llorca J; Infante J; Rodríguez-Rodríguez E; Fernández-Viadero C; Peña N; Berciano J; Combarros O
Acta Neurol Scand; 2007 Jul; 116(1):56-8. PubMed ID: 17587256
[TBL] [Abstract][Full Text] [Related]
13. Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease.
Kawamoto EM; Munhoz CD; Glezer I; Bahia VS; Caramelli P; Nitrini R; Gorjão R; Curi R; Scavone C; Marcourakis T
Neurobiol Aging; 2005 Jun; 26(6):857-64. PubMed ID: 15718044
[TBL] [Abstract][Full Text] [Related]
14. Uptake of 5-hydroxytryptamine by blood platelets in Huntington's chorea and Alzheimer type of presenile dementia.
Tukiainen E; Wikström J; Kilpeläinen H
Med Biol; 1981 Apr; 59(2):116-20. PubMed ID: 6458746
[TBL] [Abstract][Full Text] [Related]
15. The lipid peroxidation products as possible markers of Alzheimer's disease in blood.
Skoumalová A; Ivica J; Santorová P; Topinková E; Wilhelm J
Exp Gerontol; 2011 Jan; 46(1):38-42. PubMed ID: 20920571
[TBL] [Abstract][Full Text] [Related]
16. Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease.
Laske C; Leyhe T; Stransky E; Eschweiler GW; Bueltmann A; Langer H; Stellos K; Gawaz M
J Psychiatr Res; 2008 Jul; 42(9):746-51. PubMed ID: 17854831
[TBL] [Abstract][Full Text] [Related]
17. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
18. Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms.
Borroni B; Colciaghi F; Corsini P; Akkawi N; Rozzini L; Del Zotto E; Talarico G; Cattabeni F; Lenzi GL; Di Luca M; Padovani A
Neurol Sci; 2002 Dec; 23(5):207-10. PubMed ID: 12522675
[TBL] [Abstract][Full Text] [Related]
19. Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients.
Kim EJ; Cho SS; Jeong Y; Park KC; Kang SJ; Kang E; Kim SE; Lee KH; Na DL
Brain; 2005 Aug; 128(Pt 8):1790-801. PubMed ID: 15888536
[TBL] [Abstract][Full Text] [Related]
20. Decrease in GTP-sensitive high affinity agonist binding of muscarinic acetylcholine receptors in autopsied brains of dementia with Lewy bodies and Alzheimer's disease.
Shiozaki K; Iseki E
J Neurol Sci; 2004 Aug; 223(2):145-8. PubMed ID: 15337615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
